Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle Kumbier

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
JAMA Network Open|July 1, 2024
Prediction-Augmented Shared Decision-Making and Lung Cancer Screening UptakeTanner J Caverly, Renda S Wiener, Kyle Kumbier, et al.
Drug and Alcohol Dependence|February 17, 2026
Identifying the 'gray zone': Developing scalable methods to detect opioid misuse in veterans on long-term opioid therapy for painColin Macleod, Caroline Logue, Kyle Kumbier, et al.
Cancer Medicine|June 16, 2023
Mental health care utilization among men with castration-resistant prostate cancer receiving abiraterone or enzalutamidePhoebe A Tsao, Jennifer Burns, Kyle Kumbier, et al.
Cancer|March 25, 2021
Factors influencing treatment of veterans with advanced prostate cancerMegan E V Caram, Jennifer Burns, Kyle Kumbier, et al.
Cancer Medicine|February 15, 2023
Differential adoption of castration-resistant prostate cancer treatment across facilities in a national healthcare systemMegan E V Caram, Kyle Kumbier, Jennifer Burns, et al.
Cancer Medicine|August 14, 2024
Survival by first-line therapy and prognostic group among men with metastatic castration-resistant prostate cancerMegan E V Caram, Kyle Kumbier, Phoebe A Tsao, et al.
BMJ (Clinical Research Ed.)|May 23, 2023
Adverse outcomes of SARS-CoV-2 infection with delta and omicron variants in vaccinated versus unvaccinated US veterans: retrospective cohort studyAmy Sb Bohnert, Kyle Kumbier, Mazhgan Rowneki, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
JAMA Network Open|July 1, 2024
Prediction-Augmented Shared Decision-Making and Lung Cancer Screening UptakeTanner J Caverly, Renda S Wiener, Kyle Kumbier, et al.
Drug and Alcohol Dependence|February 17, 2026
Identifying the 'gray zone': Developing scalable methods to detect opioid misuse in veterans on long-term opioid therapy for painColin Macleod, Caroline Logue, Kyle Kumbier, et al.
Cancer Medicine|June 16, 2023
Mental health care utilization among men with castration-resistant prostate cancer receiving abiraterone or enzalutamidePhoebe A Tsao, Jennifer Burns, Kyle Kumbier, et al.
Cancer|March 25, 2021
Factors influencing treatment of veterans with advanced prostate cancerMegan E V Caram, Jennifer Burns, Kyle Kumbier, et al.
Cancer Medicine|February 15, 2023
Differential adoption of castration-resistant prostate cancer treatment across facilities in a national healthcare systemMegan E V Caram, Kyle Kumbier, Jennifer Burns, et al.
Cancer Medicine|August 14, 2024
Survival by first-line therapy and prognostic group among men with metastatic castration-resistant prostate cancerMegan E V Caram, Kyle Kumbier, Phoebe A Tsao, et al.
BMJ (Clinical Research Ed.)|May 23, 2023
Adverse outcomes of SARS-CoV-2 infection with delta and omicron variants in vaccinated versus unvaccinated US veterans: retrospective cohort studyAmy Sb Bohnert, Kyle Kumbier, Mazhgan Rowneki, et al.
Pageof 1